BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 35 filers reported holding BIND THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $15,000 | +66.7% | 37,601 | +840.0% | 0.00% | – |
| Q1 2016 | $9,000 | +28.6% | 4,000 | +33.3% | 0.00% | – |
| Q4 2015 | $7,000 | -50.0% | 3,000 | -5.9% | 0.00% | – |
| Q3 2015 | $14,000 | -64.1% | 3,188 | -54.6% | 0.00% | – |
| Q2 2015 | $39,000 | +11.4% | 7,020 | +10.7% | 0.00% | – |
| Q1 2015 | $35,000 | +84.2% | 6,340 | +80.6% | 0.00% | – |
| Q4 2014 | $19,000 | – | 3,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
| FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
| Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
| VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
| Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |